ESSO Advanced Course on UPPER GI Malignancy

Transcription

1 ESSO Advanced Course on UPPER GI Malignancy In association with PSSO (Polish Society of Surgical Oncology) October 2013 POZNÁN

2 ESSO Advanced Course on Upper Gi Malignancy Course directors Chair: Thomas Lehnert, Klinikum Bremen-Mitte, Bremen, DE Co-chairs: Jan Kulig, Collegium Medicum Jagiellonian University, Cracow, PL Dawid Murawa, Wielkopolska Oncological Center, Poznan, PL Wojciech Polkowski, Medical University of Lublin, PL Franco Roviello, Università degli Studi di Siena, IT Jan van Lanschot (TBC), Erasmus University of Rotterdam, NL Invited Speakers Han Bonenkamp, Radboud University Nijmegen Medical Center, Nijmegen, NL Santiago González-Moreno, MD Anderson Cancer Center, Madrid, SP Tomasz Grodzki, Specialistic Hospital, Zdunowo, Szczecin, PL Michael Hünerbein, Helios Klinikum Berlin-Buch, Berlin, DE, Wojciech Kielan, Clinic of General and Surgical Oncology University Hospital, Wroclaw, PL Józef Kozak, Kopernik Specialistic Hospital, Łódź, PL Wieslaw Kruszewski, Gdynia Centre of Oncology, Gdynia, PL Konstantinos G. Lasithiotakis, University of Crete, Heraklion, GR Piotr Martenka, Greater Poland Cancer Center, Poznan, PL Piotr Milecki, The Greater Poland Cancer Center, Poznán, PL Dariusz Nejc, Medical University, Łódź, PL Tadeusz Orlowski, Institute of Tuberculose and Lung Deseases, Warsaw, PL Guillaume Piessen, Hôpital Universitaire Claude Huriez, Lille, FR Piotr Potemski, Klinica Chemioterapii Nowotworów, Lódz, PL Jaroslaw Reguła, The Maria Skłodowska-Curie Institute of Oncology, Warsaw, PL Piotr Richter, Collegium Medicum Jagiellonian University, Cracow, PL Janusz Wójcik, Specialist Hospital Prof. A. Sokolowski, Szczecin-Zdunovo, PL

3 Aim of the Course The aim of the two day course is to provide a comprehensive overview of all aspects of diagnosis, surgical and multimodality treatment of primary and metastatic esophageal and gastric cancer. This course also aims at stimulating an intensive discussion between delegates and faculty to critically review alternative clinical approaches and to develop an in-depth understanding of current evidence-based treatment concepts. Educational outcomes After the course delegates are expected to develop an in-depth evidence-based understanding of Current diagnostic approaches to esophageal and gastric cancer Surgical technical aspects of radical resection, lymphadenectomy, reconstruction Minimally invasive surgical techniques Perioperative management including fast track concepts and im munonutrition Multimodality treatment concepts Management of emergency situations and surgical palliation Educational Methods Presentations with continuous audience participation Demonstration of live operations Multidisciplinary presentations Extensive room for discussions Ideal Course candidates UGI specialists and surgeons in UGI specialist training Experienced general surgeons treating UGI cancer Course Coordination Ana Galán Tel Ana.galan@essoweb.org

4 Local Organisation Anita Kostecka . Arkadiusz Spychala . Tel Course Venue The Greater Poland Cancer Center Garbary 15 Str Poznan (PL) Accommodation For accommodation, please complete the accommodation form on Partnerships This course is organised in association with the Polish Society of Surgical Oncology (PSS0) and with the support of the The Greater Poland Cancer Center Participation fee Attendance is limited to 80 participants and admittance is on first come first served basis. The participation fee is 90 for ESSO, PSSO and PSA members and 120 for non-members. It includes registration to the course, coffee breaks and lunches and a social dinner. Application procedure The application form must be completed on by 30th September Accreditation Accreditation has been requested from the Accreditation Council of Oncology in Europe (ACOE).

5 ESSO Advanced Course on Upper GI Malignancy Programme Friday 18 October 08:30-10:20 Oesophageal Cancer (Session 1) Th. Lehnert, D. Murawa 08:30-08:40 Welcome Th. Lehnert, D. Murawa 08:40-09:00 Clinical staging of oesophageal cancer - what is necessary? J. van Lanschot 09:00-09:20 Surveillance strategies and treatment options for Barrett Mucosa J. Regula 09:20-09:40 Endoscopic Treatment for clinical T1 Oesophageal Cancer - pro W. Kruszewski 09:40-10:00 Endoscopic Treatment for clinical T1 Oesophageal Cancer - contra J. Piessen 10:00-10:20 Minimally Invasive Oesophageal Resection T. Grodzki 10:20-11:00 Coffee break 11:00-12:45 Oesophageal Cancer (Session 2) J. van Lanschot, T. Orlowski 11:00-11:20 How extended should lymphadenectomy be? T. van Lanschot 11:20-11:40 Transhiatal or transthoracic approach J. Kozak 11:40-12:00 Technical aspects of reconstruction - what is learned from randomized trials? (hand vs stapled anastomosis, drains, pyloroplasty, route of reconstruction etc) T. Orlowski 12:00-12:20 Fast track management of esophagectomy J. Piessen 12:20-12:40 How I do intrathoracic esophagogastric anastomoses J. van Lanschot, Th. Lehnert, P. Richter 12:40-14:00 Lunch 14:00-15:45 Oesophageal Cancer (Session 3) T. Grodzki, G. Piessen 14:00-14:20 Neoadjuvant multimodality treatment - pro J. Wójcik

6 14:20-14:40 Neoadjuvant multimodality treatment - contra Th. Lehnert 14:40-15:00 The value of PET studies in the management of oesophageal cancer K. Lasithiotakis 15:00-15:20 Definitive Radiochemotherapy P. Milecki 15:20-15:40 What is needed in follow-up? D. Murawa 15:40-16:15 Coffee break 16:15-17:35 Oesophageal Cancer (Session 4) T. Orlowski, F. Roviello 16:15-16:35 Is centralization necessary? J. van Lanschot 16:35-16:55 Is palliative esophageal resection justified? F. Roviello 16:55-17:15 Palliation of esophageal stenosis - endoscopic management M. Hünerbein 17:15-17:35 Palliation of esophageal stenosis - radiotherapy and systemic treatment P. Martenka 19:30 Social dinner Saturday 19 October 08:25-10:30 Gastric Cancer (Session 1) H. Bonenkamp, W. Polkowski 08:25-08:30 Welcome H. Bonenkamp, W. Polkowski 08:30-08:50 Clinical staging of gastric cancer - is laparoscopy necessary S. González-Moreno 08:50-09:10 Preoperative management of the malnourished patient G. Piessen 09:10-09:30 Endoscopic treatment of early gastric cancer T. Starzysnka 09:30-09:50 Sentinel node guided treatment of EGC D. Nejc 09:50-10:10 Minimally Invasive Surgery for Gastric Cancer H. Bonenkamp 10:10-10:45 Coffee break

7 10:45-12:45 Gastric Cancer (Session 2) F. Roviello, J. Kulig 10:45-11:05 Neoadjuvant treatment - pro P. Potemski 11:05-11:25 Neoadjuvant treatment - contra Th. Lehnert 11:25-11:45 Signet cell gastric carcinoma: a need for specific treatment strategies? G. Piessen 11:45-12:05 Partial or total gastrectomy? W. Polkowski 12:05-12:25 How extended should lymphadenectomy be (D1-D4)? J. Kulig 12:25-12:45 What is the role of extended gastrectomy? H. Bonenkamp 12:45-13:45 Lunch Break 13:45-15:45 Gastric Cancer (Session 3) P. Richter, S. González-Moreno 13:45-14:05 Reconstruction after total gastrectomy W. Kielan 14:05-14:25 Is there a place for adjuvant therapy? J. Kulig 14:25-14:45 Emergency treatment of bleeding or perforated gastric cancer W. Polkowski 14:45-15:05 The role of peritoneal cytology in the management of gastric cancer G. Piessen 15:05-15:25 Follow-up after potentially curative gastrectomy P. Richter 15:25-16:15 Coffee break 16:15-17:55 Gastric Cancer (Session 4) W. Kielan, Th. Lehnert 16:15-16:35 Palliative Gastrectomy in Metastatic Disease K. Lasithiotakis 16:35-16:55 Management of resectable distant metastases? M. Hünerbein 16:55-17:15 Treatment of peritoneal carcinomatosis S. González-Moreno 17:15-17:35 Treatment options for palliation of obstruction F. Roviello 17:35-17:55 Systemic chemotherapy or best supportive care for incurable disease? P. Potemski Conclusions

8 The advanced course is supported by: ESSO is grateful for the continuous support of its corporate sponsors European Society of Surgical Oncology (ESSO) Avenue E. Mounier 83 B 1200 Brussels Tel: +32 (0) Fax : +32 (0) info@essoweb.org Website :